[1]
Kumar Sarker, U. et al. 2022. Bioequivalence study of BETALOC-XR™ (Drug International Ltd, Bangladesh) and METOPROLOL 100 STADA™ (STADA Pharm Gmbh, Germany) as open-label, two-way crossover and randomized fashion among healthy male volunteers. Asian Journal of Pharmaceutical Research and Development. 10, 6 (Dec. 2022), 9–13. DOI:https://doi.org/10.22270/ajprd.v10i6.1184.